Health & Biotech
Check out the latest news, insights and unique analysis brought to you by Stockhead's team of business journalists and industry experts on Avecho.
RELATED STOCKHEAD STORIES
Health & Biotech
Check Up: Anteotech riding high with $1.9m refund, and Avecho inks supply agreement for CBD arthritis treatment
News
10 at 10: Investors are swarming around these ASX stocks this morning
Health & Biotech
ASX Health Stocks: Genetic Technologies jumps after EasyDNA acquisition ups cash receipts by $850k
Health & Biotech
ScoPo’s Powerplays: As focus turns to Delta variant, these ASX health stocks are profiting from COVID-19 testing
Guides
CBD Oil: The ultimate investor’s guide to a potential $64 billion global market
News
Closing Bell: ASX retreats, led by 2pc drop in energy
Health & Biotech
ASX Health Stocks: Amplia begins Phase 2 trial for pancreatic cancer, while Avecho commences Phase 1 of cannabis gel
News
Weed Week: Cannabis trade shows and Europe imports medicinal marijuana
Health & Biotech
Weed Week: Major shifts in US legislation set to open the door for some ASX cannabis stocks
News
Market highlights and 5 ASX small caps to watch on Monday
Health & Biotech
Biotech Avecho just got the all-clear for human cannabis trials
Experts
ScoPo’s health powerplays: What to look for this earnings season
News
Rise and Shine: What you need to know before the ASX opens
Experts
ScoPo’s powerplays: Jazz Pharma’s $9.4b deal highlights pot plays
Health & Biotech
‘Pure biotech’ play Avecho is making a ‘terrifying’ move. Will it pay off?
Health & Biotech
Check Up: Rhythm Biosciences shares just keep on soaring
News
